In patients with HBV-associated HCC (HBV-HCC), the NKG2A/NKG2D ratio in NK cells is significantly elevated, both serving as a predictor of tumor progression and correlating positively with NK cell functional suppression. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.